| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.18 | 0.007 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.22 | 0.008 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.009 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.46 | 0.009 |